Medi Caps Ltd (MEDICAPS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 723558,
    "name": "Medi Caps",
    "stock_name": "Medi Caps",
    "full_name": "Medi Caps Ltd",
    "name_url": "stocks-analysis/medi-caps",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.00",
    "chg": -1.25,
    "chgp": "-5.38%",
    "dir": -1,
    "prev_price": "23.25",
    "mcapval": "27.43 Cr",
    "mcap": "Micro Cap",
    "scripcode": 523144,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE442D01010",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": "3.71 k",
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medi-caps-723558-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Medi Caps Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-medi-caps-ltd-latest-results-good-or-bad-3835827",
        "imagepath": "",
        "date": "2026-02-12 19:56:36",
        "description": "Medi Caps Ltd's latest financial results indicate a company facing significant operational challenges. In the quarter ended December 2025, the company reported net sales of ₹4.30 crores, reflecting a sequential improvement of 112.87% from the previous quarter. However, this increase is overshadowed by a year-on-year decline of 56.61%, highlighting persistent structural issues within its core capsule manufacturing business.\n\nThe company posted a net loss of ₹0.77 crores for the quarter, which represents a 62.44% deterioration compared to the same period last year. The operating margin was deeply negative at -24.71%, indicating ongoing operational inefficiencies and an inability to generate sustainable sales volumes. Furthermore, the return on equity has fallen to -4.84%, reflecting the company's struggles to provide returns on the capital employed.\n\nDespite the sequential revenue growth, the overall financia..."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22.99 Amidst Continued Weak Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs2299-amidst-continued-weak-performance-3834622",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3834622.png",
        "date": "2026-02-12 09:52:51",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.22.99 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance."
      },
      {
        "title": "Are Medi Caps Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-medi-caps-ltd-latest-results-good-or-bad-3833535",
        "imagepath": "",
        "date": "2026-02-11 19:46:20",
        "description": "Medi Caps Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, characterized by a substantial net loss of ₹1.82 crores, a stark contrast to a profit of ₹0.31 crores in the same quarter last year. Revenue also saw a dramatic decline, falling to ₹2.02 crores, which represents a 75.63% decrease year-on-year and the lowest quarterly sales figure in recent history. This revenue drop indicates severe demand issues or operational disruptions within the company.\n\nThe company's operating margin was reported at a deeply negative 144.28%, highlighting severe operational inefficiencies and an inability to cover basic costs. Employee costs remained high, consuming over 90% of total revenue, which exacerbates the financial strain. The return on equity has also deteriorated, with a five-year average of just 2.03%, reflecting poor capital efficiency.\n\nSequentially, the results show a declin..."
      },
      {
        "title": "Medi Caps Q3 FY26: Losses Deepen as Revenue Struggles Continue",
        "link": "https://www.marketsmojo.com/news/result-analysis/medi-caps-q3-fy26-losses-deepen-as-revenue-struggles-continue-3833685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCaps_quaterlyResult_3833685.png",
        "date": "2026-02-11 18:34:28",
        "description": "Medi Caps Ltd., one of India's established manufacturers of empty hard gelatine capsules, posted a net loss of ₹0.77 crores in Q3 FY26, marking its third consecutive quarter of losses. The Madhya Pradesh-based pharmaceutical company, with a market capitalisation of ₹31.00 crores, continues to face severe operational headwinds as revenue declined 56.61% year-on-year to ₹4.30 crores during the quarter ended December 2025."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24 Amidst Continued Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs24-amidst-continued-weakness-3828714",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3828714.png",
        "date": "2026-02-09 11:07:08",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.24 today, marking a significant decline in its stock price amid ongoing financial headwinds and sector underperformance."
      },
      {
        "title": "Medi Caps Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medi-caps-ltd-is-rated-strong-sell-3825741",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_mojoScore_3825741.png",
        "date": "2026-02-07 10:10:32",
        "description": "Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24.16 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs2416-amidst-continued-downtrend-3824341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3824341.png",
        "date": "2026-02-06 11:20:00",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.24.16 on 6 Feb 2026, marking a significant decline amid a sustained downward trend. The stock has now fallen for three consecutive sessions, shedding 4.77% over this period, reflecting ongoing pressures on its market valuation."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low Amidst Continued Weak Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-amidst-continued-weak-performance-3822007",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3822007.png",
        "date": "2026-02-05 09:44:36",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recently touched a new 52-week low, closing just 1.96% above its lowest price of Rs 24.51. This marks a significant milestone in the stock’s ongoing decline, reflecting persistent pressures on the company’s financial and market performance."
      },
      {
        "title": "Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24.51 Amidst Weak Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/medi-caps-ltd-stock-falls-to-52-week-low-of-rs2451-amidst-weak-financial-metrics-3820848",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/MediCapsLtd_priceRelatedfactors_3820848.png",
        "date": "2026-02-04 15:36:30",
        "description": "Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.24.51 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance."
      }
    ],
    "total": 97,
    "sid": "723558",
    "stock_news_url": "https://www.marketsmojo.com/news/medi-caps-723558"
  },
  "announcements": [
    {
      "caption": "Unaudited Standalone & Consolidated Financial Results For The Quarter & Nine Month Ended 31.12.2025",
      "datetime": "11-Feb-2026",
      "details": "Submission of unaudited standalone & consolidated financial results for the quarter & nine month ended 31.12.2025.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Dated 11.02.2026",
      "datetime": "11-Feb-2026",
      "details": "Outcome of Board Meeting Dated 11.02.2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for (Serial No. 04/2025-26) Of The Company Scheduled To Be Held On Wednesday 11Th Day Of February 2026 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
      "datetime": "04-Feb-2026",
      "details": "Medi Caps Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve 1.To consider and approve the Standalone as well as Consolidated Un-Audited Financial Results of the Company for the quarter as well as nine months ended on 31st December 2025 along with the Limited Review Report thereon. 2.Other routine matters with the permission of chair.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has declared <strong>15%</strong> dividend, ex-date: 20 Sep 12",
          "dt": "2012-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medi Caps Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Mar 13",
          "dt": "2013-03-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Medi Caps Ltd latest results good or bad?

2026-02-12 19:56:36

Medi Caps Ltd's latest financial results indicate a company facing significant operational challenges. In the quarter ended December 2025, the company reported net sales of ₹4.30 crores, reflecting a sequential improvement of 112.87% from the previous quarter. However, this increase is overshadowed by a year-on-year decline of 56.61%, highlighting persistent structural issues within its core capsule manufacturing business. The company posted a net loss of ₹0.77 crores for the quarter, which represents a 62.44% deterioration compared to the same period last year. The operating margin was deeply negative at -24.71%, indicating ongoing operational inefficiencies and an inability to generate sustainable sales volumes. Furthermore, the return on equity has fallen to -4.84%, reflecting the company's struggles to provide returns on the capital employed. Despite the sequential revenue growth, the overall financia...

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.22.99 Amidst Continued Weak Performance

2026-02-12 09:52:51

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a fresh 52-week low of Rs.22.99 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance.

Read full news article

Are Medi Caps Ltd latest results good or bad?

2026-02-11 19:46:20

Medi Caps Ltd's latest financial results for Q2 FY26 reveal significant operational challenges, characterized by a substantial net loss of ₹1.82 crores, a stark contrast to a profit of ₹0.31 crores in the same quarter last year. Revenue also saw a dramatic decline, falling to ₹2.02 crores, which represents a 75.63% decrease year-on-year and the lowest quarterly sales figure in recent history. This revenue drop indicates severe demand issues or operational disruptions within the company. The company's operating margin was reported at a deeply negative 144.28%, highlighting severe operational inefficiencies and an inability to cover basic costs. Employee costs remained high, consuming over 90% of total revenue, which exacerbates the financial strain. The return on equity has also deteriorated, with a five-year average of just 2.03%, reflecting poor capital efficiency. Sequentially, the results show a declin...

Read full news article

Medi Caps Q3 FY26: Losses Deepen as Revenue Struggles Continue

2026-02-11 18:34:28

Medi Caps Ltd., one of India's established manufacturers of empty hard gelatine capsules, posted a net loss of ₹0.77 crores in Q3 FY26, marking its third consecutive quarter of losses. The Madhya Pradesh-based pharmaceutical company, with a market capitalisation of ₹31.00 crores, continues to face severe operational headwinds as revenue declined 56.61% year-on-year to ₹4.30 crores during the quarter ended December 2025.

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24 Amidst Continued Weakness

2026-02-09 11:07:08

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.24 today, marking a significant decline in its stock price amid ongoing financial headwinds and sector underperformance.

Read full news article

Medi Caps Ltd is Rated Strong Sell

2026-02-07 10:10:32

Medi Caps Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24.16 Amidst Continued Downtrend

2026-02-06 11:20:00

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a fresh 52-week low of Rs.24.16 on 6 Feb 2026, marking a significant decline amid a sustained downward trend. The stock has now fallen for three consecutive sessions, shedding 4.77% over this period, reflecting ongoing pressures on its market valuation.

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low Amidst Continued Weak Performance

2026-02-05 09:44:36

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recently touched a new 52-week low, closing just 1.96% above its lowest price of Rs 24.51. This marks a significant milestone in the stock’s ongoing decline, reflecting persistent pressures on the company’s financial and market performance.

Read full news article

Medi Caps Ltd Stock Falls to 52-Week Low of Rs.24.51 Amidst Weak Financial Metrics

2026-02-04 15:36:30

Medi Caps Ltd, a player in the Pharmaceuticals & Biotechnology sector, has recorded a new 52-week low of Rs.24.51 today, marking a significant decline in its stock price amid ongoing financial pressures and subdued market performance.

Read full news article

View All News